These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 26492964
41. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. Viswanath V, Myles A, Dayal R, Aggarwal A. J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500 [Abstract] [Full Text] [Related]
42. Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study. Pyne L, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Keystone EC, Pope JE, CATCH Investigators. J Rheumatol; 2012 Nov; 39(11):2081-7. PubMed ID: 22942265 [Abstract] [Full Text] [Related]
43. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. Andersson ML, Svensson B, Bergman S. J Rheumatol; 2013 Dec; 40(12):1977-85. PubMed ID: 24187108 [Abstract] [Full Text] [Related]
44. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, Helliwell PS. Arthritis Rheum; 2013 Jun; 65(6):1504-9. PubMed ID: 23529837 [Abstract] [Full Text] [Related]
45. Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment. Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Capalbo G, Leccese I, Bogdanos D, Spinelli FR, Alessandri C, Valesini G, Conti F. Semin Arthritis Rheum; 2017 Aug; 47(1):53-64. PubMed ID: 28465078 [Abstract] [Full Text] [Related]
46. Self-assessment of disease activity by patients with rheumatoid arthritis. Hanly JG, Mosher D, Sutton E, Weerasinghe S, Theriault D. J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920 [Abstract] [Full Text] [Related]
47. Ultrasonography and detection of subclinical joints and tendons involvements in Systemic Lupus erythematosus (SLE) patients: A cross-sectional multicenter study. Salliot C, Denis A, Dernis E, Andre V, Perdriger A, Albert JD, Mammou Mraghni S, Griffoul-Espitalier I, Hamidou M, Le Goff B, Joulin SJ, Marhadour T, Richez C, Poursac N, Lazaro E, Rist S, Corondan A, Quinten C, Martaillé V, Valéry A, Ducourau E. Joint Bone Spine; 2018 Dec; 85(6):741-745. PubMed ID: 29454670 [Abstract] [Full Text] [Related]
48. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study. Lutf A, Poil AR, Hammoudeh M. Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269 [Abstract] [Full Text] [Related]
49. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials. Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB. J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488 [Abstract] [Full Text] [Related]
50. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation. Hu Y, Li H, Li WH, Meng HX, Fan YZ, Li WJ, Ji YT, Zhao H, Zhang L, Jin XM, Zhang FM. Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723 [Abstract] [Full Text] [Related]
51. Patients with active rheumatoid arthritis but only few tender and swollen joints: a subgroup with impaired short term outcome. Fiehn C, Kessler S, Drexler W, Lorenz HM. Rheumatol Int; 2009 Apr; 29(6):655-61. PubMed ID: 18998141 [Abstract] [Full Text] [Related]
52. Systemic lupus erythematosus patients in the low-latitude plateau of China: altitudinal influences. Qian G, Ran X, Zhou CX, Deng DQ, Zhang PL, Guo Y, Luo JH, Zhou XH, Xie H, Cai M. Lupus; 2014 Dec; 23(14):1537-45. PubMed ID: 25059490 [Abstract] [Full Text] [Related]
53. Safety and efficacy of etanercept-methotrexate combination therapy in patients with rhupus: an observational study of non-glucocorticoid treatment for rheumatic diseases. Yang BB, Xiao H, Li XJ, Zheng M. Discov Med; 2018 Jan; 25(135):14-20. PubMed ID: 29466690 [Abstract] [Full Text] [Related]
54. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Kapral T, Dernoschnig F, Machold KP, Stamm T, Schoels M, Smolen JS, Aletaha D. Arthritis Res Ther; 2007 Jan; 9(4):R72. PubMed ID: 17662115 [Abstract] [Full Text] [Related]
55. Serum human cartilage glycoprotein-39 levels in patients with systemic lupus erythematosus. Wcisło-Dziadecka D, Kotulska A, Brzezińska-Wcisło L, Kucharz EJ, Lis-Swiety A, Kamińska-Wiciorek G. Pol Arch Med Wewn; 2009 Dec; 119(12):777-84. PubMed ID: 20010462 [Abstract] [Full Text] [Related]
56. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? Soubrier M, Zerkak D, Gossec L, Ayral X, Roux C, Dougados M. J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906 [Abstract] [Full Text] [Related]
57. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers. Chandrashekara S, Priyanka BU. Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750 [Abstract] [Full Text] [Related]
58. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. Uribe AG, Vilá LM, McGwin G, Sanchez ML, Reveille JD, Alarcón GS. J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356 [Abstract] [Full Text] [Related]
59. Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count. Germain G, Worley K, MacKnight SD, Rubin B, Bell CF, Laliberté F, Urosevic A, Sheng Duh M, Concoff A. Lupus Sci Med; 2024 Apr 03; 11(1):. PubMed ID: 38575172 [Abstract] [Full Text] [Related]
60. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Aggarwal R, Sequeira W, Kokebie R, Mikolaitis RA, Fogg L, Finnegan A, Plaas A, Block JA, Jolly M. Arthritis Care Res (Hoboken); 2011 Jun 03; 63(6):891-8. PubMed ID: 21312346 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]